Taysha Gene Therapies, Inc. Share Price
TSHATaysha Gene Therapies, Inc. Stock Performance
Open $4.33 | Prev. Close $4.37 | Circuit Range N/A |
Day Range $4.20 - $4.50 | Year Range $1.05 - $5.50 | Volume 3,66,971 |
Average Traded $4.38 |
Taysha Gene Therapies, Inc. Share Price Chart
About Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Taysha Gene Therapies, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $4.33 | $4.38 | +0.00% |
12-Nov-25 | $4.33 | $4.38 | +2.10% |
11-Nov-25 | $3.85 | $4.29 | +10.14% |
10-Nov-25 | $3.90 | $3.90 | +1.30% |
07-Nov-25 | $3.90 | $3.85 | -1.66% |
06-Nov-25 | $4.02 | $3.91 | -2.71% |
05-Nov-25 | $4.46 | $4.02 | -5.88% |
FAQs on Taysha Gene Therapies, Inc. Share Price
Can I buy Taysha Gene Therapies, Inc. shares in India?
What is the share price of Taysha Gene Therapies, Inc.?
What is the 5 year returns of Taysha Gene Therapies, Inc.?
What are the high & low stock price of Taysha Gene Therapies, Inc. today?
What is the 52-week high and low of Taysha Gene Therapies, Inc. stock?